INTECH BIOPHARM LTD.
- Country
- 🇹🇼Taiwan
- Ownership
- Public
- Established
- 2010-01-01
- Employees
- 82
- Market Cap
- -
Clinical Trials
11
Trial Phases
4 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (11 trials with phase data)• Click on a phase to view related trials
Bioequivalence Between Albuterol Sulfate Inhalation Aerosol 108mcg Per Actuation and Proair HFA (Albuterol Sulfate) Inhalation Aerosol 90mcg Per Actuation in Healthy Volunteers Under Fasting Conditions
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2022-03-29
- Last Posted Date
- 2024-03-18
- Lead Sponsor
- Intech Biopharm Ltd.
- Target Recruit Count
- 60
- Registration Number
- NCT05300087
- Locations
- 🇨🇳
Tamshui Mackay Memorial Hospital, New Taipei City, Taiwan
Clinical Equivalence of Budesonide HFA MDI Versus Budesonide Turbuhaler in Mild to Moderate Chinese Asthma Patients
- Conditions
- Asthma
- Interventions
- First Posted Date
- 2021-12-09
- Last Posted Date
- 2021-12-09
- Lead Sponsor
- Intech Biopharm Ltd.
- Target Recruit Count
- 270
- Registration Number
- NCT05152355
- Locations
- 🇨🇳
Peking University People's Hospital, Beijing, Beijing, China
🇨🇳The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China
🇨🇳Meizhou People's Hospital, Meizhou, Guangdong, China
Pharmacodynamic Equivalence of the Test and Reference Metered Dose Inhalers (MDIs) Containing Albuterol Sulfate in Adult Patients with Stable Mild Asthma
- Conditions
- Mild Asthma
- Interventions
- Other: Albuterol Sulfate inhalation PlaceboOther: Methacholine
- First Posted Date
- 2021-06-03
- Last Posted Date
- 2025-02-17
- Lead Sponsor
- Intech Biopharm Ltd.
- Target Recruit Count
- 148
- Registration Number
- NCT04912596
- Locations
- 🇮🇳
Dr. Jivraj Mehta Smarak Health Foundation, Ahmedabad, India
🇮🇳KLEs Dr Prabhakar Kore Hospital & MRC, Belagave, India
🇮🇳NRS Medical College and Hospital, Kolkata, India
Bioequivalence Between Albuterol Sulfate Inhalation Aerosol 108 mcg Per Actuation and Proair HFA (Albuterol Sulfate) Inhalation Aerosol 90 mcg Per Actuation in Healthy Volunteers Under Fasting Conditions
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2021-03-18
- Last Posted Date
- 2024-03-18
- Lead Sponsor
- Intech Biopharm Ltd.
- Target Recruit Count
- 60
- Registration Number
- NCT04803734
- Locations
- 🇨🇳
Tamshui Mackay Memorial Hospital, New Taipei City, Taiwan
A Bioequivalence Pivotal Study of SYN010 HFA Inhaler and Symbicort® 160/4.5 in Healthy Volunteers Without Charcoal Block
- First Posted Date
- 2020-07-31
- Last Posted Date
- 2020-07-31
- Lead Sponsor
- Intech Biopharm Ltd.
- Target Recruit Count
- 99
- Registration Number
- NCT04494321
- Locations
- 🇨🇳
Clinical Pharmacology Unit of Mackay Memorial Hospital Tamshui Branch, New Taipei City, Taiwan
- Prev
- 1
- 2
- 3
- Next